Literature DB >> 18562127

Dystrophin: from non-ischemic cardiomyopathy to ischemic cardiomyopathy.

Qiang Sun Zheng1, Wan Gang Guo, Zi Fan Lu, Xiao Qin Shi, Fei Fei Su, Hua Li.   

Abstract

Dystrophin and its associated proteins form a scaffold underneath the cardiomyocyte membrane and connect the intracellular cytoskeleton to the extracellular matrix. Dystrophin localizes at the X chromosome, whose mutations might result in Duchenne muscular dystrophy, Becker muscular dystrophy and X-linked dilated cardiomyopathy. In addition to these genetic dilated cardiomyopathies, some acquired dilated cardiomyopathy like viral dilated cardiomyopathy is also related to dystrophin disruption or aberrant cleavage. In this review, we summarize the structure and distribution of dystrophin and researches of dystrophin in genetic and viral dilated cardiomyopathy. Moreover, we hypothesize that dystrophin play a critical role in ventricular remodeling in ischemic myocardium and treatment targeting restoration of dystrophin onto membrane could benefit for ischemic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562127     DOI: 10.1016/j.mehy.2008.04.004

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.

Authors:  Dawn A Delfín; Kara E Zang; Kevin E Schill; Nikita T Patel; Paul M L Janssen; Subha V Raman; Jill A Rafael-Fortney
Journal:  Neuromuscul Disord       Date:  2012-06-29       Impact factor: 4.296

2.  Cardiomyopathy in the mouse model of Duchenne muscular dystrophy caused by disordered secretion of vascular endothelial growth factor.

Authors:  Dariusz Nowak; Hanna Kozlowska; Jerzy S Gielecki; Jan Rowinski; Anna Zurada; Krzysztof Goralczyk; Wladimir Bozilow
Journal:  Med Sci Monit       Date:  2011-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.